More than 70% of surveyed U.S. ophthalmologists anticipate a fundamentally transformed approach to managing nAMD and DME within the next five years.< ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

As noisy labels severely degrade the generalization performance of deep neural networks, learning from noisy labels (robust training) is becoming an important task in modern deep learning applications ...

Berlin: Bayer has received approval from the European Commission (EC) for a label extension in the European Union (EU) for Eylea 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection) with ...

The European Commission (EC) has granted a label extension in the European Union (EU) for Eylea 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection) with extended treatment intervals of up to 6 ...

Shams Charania has branded the Dallas Mavericks' frontcourt the best in the NBA after they drafted Cooper Flagg.